Company / Free Cash Flow per Share
Anika Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.30
FY2025
5-year range
-$0.49 / $2.39
FY2021-FY2025
Trend
+290.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed +290% YoY in FY2025, a notable deviation from the 9-year average annual change of +30%.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of -32.2%.
Improved from $-0.49 to $0.30 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -27.4%
- 5-Year CAGR
- -32.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 290.3% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +290.3% |
| FY2024 | -$0.16 | +67.8% |
| FY2023 | -$0.49 | -162.3% |
| FY2022 | $0.79 | -66.8% |
| FY2021 | $2.39 | +12.8% |
| FY2020 | $2.12 | -5.6% |
| FY2019 | $2.24 | +215.3% |
| FY2018 | $0.71 | -66.1% |
| FY2017 | $2.10 | -17.9% |
| FY2016 | $2.56 | +53.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026